Key result
Inferior vena cava filters serve as an alternative for venous thromboembolic disease when anticoagulation fails or is contraindicated, though evidence is limited and complications can occur.
Inferior vena cava filters serve as an alternative for venous thromboembolic disease when anticoagulation is unsuitable, though their use is limited by a lack of robust evidence and potential complications.
Reserve IVC filters for select anticoagulation-ineligible cases with vigilant follow-up; leaves open the need for randomized trials on outcomes.
Venous thromboembolic disease is associated with significant morbidity and mortality. Anticoagulation has been the mainstay of treatment and prevention. Unfortunately, anticoagulation frequently fails or is contraindicated. Use of inferior vena cava filters can be an effective alternative in these scenarios. Though inferior vena cava filters have been used for > 4 decades, the evidence behind their use is limited. Use of IVC filters is associated with both minor and major complications. More randomized prospective trials are needed to evaluate these devices. In this article, we review issues concerning the use of inferior vena cava filters.
No takes yet. Share an insight, caveat, or question.
Sahni et al. (2011) conducted a review in Venous thromboembolic disease. Inferior vena cava filters was evaluated. Inferior vena cava filters serve as an alternative for venous thromboembolic disease when anticoagulation fails or is contraindicated, though evidence is limited and complications can occur.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: